目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Celiac Diseases Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Celiac Diseases Drugs Market 2018 - 2022 ($ million)
4.2 Therapy segment analysis 2018 - 2022
Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
4.3 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Therapy
6.1 Market segments
Chart on Therapy - Market share 2023-2028 (%)
Data Table on Therapy - Market share 2023-2028 (%)
6.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
6.3 First line treatment - Market size and forecast 2023-2028
Chart on First line treatment - Market size and forecast 2023-2028 ($ million)
Data Table on First line treatment - Market size and forecast 2023-2028 ($ million)
Chart on First line treatment - Year-over-year growth 2023-2028 (%)
Data Table on First line treatment - Year-over-year growth 2023-2028 (%)
6.4 Second-line treatment - Market size and forecast 2023-2028
Chart on Second-line treatment - Market size and forecast 2023-2028 ($ million)
Data Table on Second-line treatment - Market size and forecast 2023-2028 ($ million)
Chart on Second-line treatment - Year-over-year growth 2023-2028 (%)
Data Table on Second-line treatment - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Therapy
Market opportunity by Therapy ($ million)
Data Table on Market opportunity by Therapy ($ million)

7 Market Segmentation by Route of Administration
7.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
7.3 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ million)
Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
7.4 Parenteral - Market size and forecast 2023-2028
Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share by geography 2023-2028 (%)
Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp. - Overview
Adaptive Biotechnologies Corp. - Product / Service
Adaptive Biotechnologies Corp. - Key news
Adaptive Biotechnologies Corp. - Key offerings
12.4 Almirall SA
Almirall SA - Overview
Almirall SA - Product / Service
Almirall SA - Key news
Almirall SA - Key offerings
12.5 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.6 AMYRA Biotech AG
AMYRA Biotech AG - Overview
AMYRA Biotech AG - Product / Service
AMYRA Biotech AG - Key offerings
12.7 BioLineRx Ltd.
BioLineRx Ltd. - Overview
BioLineRx Ltd. - Product / Service
BioLineRx Ltd. - Key offerings
12.8 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.9 Calypso Biotech BV
Calypso Biotech BV - Overview
Calypso Biotech BV - Product / Service
Calypso Biotech BV - Key offerings
12.10 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.11 Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. - Overview
Glenmark Pharmaceuticals Ltd. - Product / Service
Glenmark Pharmaceuticals Ltd. - Key offerings
12.12 ImmunogenX Inc.
ImmunogenX Inc. - Overview
ImmunogenX Inc. - Product / Service
ImmunogenX Inc. - Key offerings
12.13 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.14 Precigen Inc.
Precigen Inc. - Overview
Precigen Inc. - Key offerings
12.15 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.16 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Celiac Diseases Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Therapy - Market share 2023-2028 (%)
Exhibits33: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Therapy
Exhibits35: Data Table on Comparison by Therapy
Exhibits36: Chart on First line treatment - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on First line treatment - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on First line treatment - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on First line treatment - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Second-line treatment - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Second-line treatment - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Second-line treatment - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Second-line treatment - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Therapy ($ million)
Exhibits45: Data Table on Market opportunity by Therapy ($ million)
Exhibits46: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits47: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Route of Administration
Exhibits49: Data Table on Comparison by Route of Administration
Exhibits50: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by Route of Administration ($ million)
Exhibits59: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2023-2028 (%)
Exhibits62: Data Table on Market share by geography 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Data Tables on Market opportunity by geography ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: Adaptive Biotechnologies Corp. - Overview
Exhibits110: Adaptive Biotechnologies Corp. - Product / Service
Exhibits111: Adaptive Biotechnologies Corp. - Key news
Exhibits112: Adaptive Biotechnologies Corp. - Key offerings
Exhibits113: Almirall SA - Overview
Exhibits114: Almirall SA - Product / Service
Exhibits115: Almirall SA - Key news
Exhibits116: Almirall SA - Key offerings
Exhibits117: Amgen Inc. - Overview
Exhibits118: Amgen Inc. - Product / Service
Exhibits119: Amgen Inc. - Key news
Exhibits120: Amgen Inc. - Key offerings
Exhibits121: AMYRA Biotech AG - Overview
Exhibits122: AMYRA Biotech AG - Product / Service
Exhibits123: AMYRA Biotech AG - Key offerings
Exhibits124: BioLineRx Ltd. - Overview
Exhibits125: BioLineRx Ltd. - Product / Service
Exhibits126: BioLineRx Ltd. - Key offerings
Exhibits127: Bristol Myers Squibb Co. - Overview
Exhibits128: Bristol Myers Squibb Co. - Product / Service
Exhibits129: Bristol Myers Squibb Co. - Key news
Exhibits130: Bristol Myers Squibb Co. - Key offerings
Exhibits131: Calypso Biotech BV - Overview
Exhibits132: Calypso Biotech BV - Product / Service
Exhibits133: Calypso Biotech BV - Key offerings
Exhibits134: GlaxoSmithKline Plc - Overview
Exhibits135: GlaxoSmithKline Plc - Business segments
Exhibits136: GlaxoSmithKline Plc - Key news
Exhibits137: GlaxoSmithKline Plc - Key offerings
Exhibits138: GlaxoSmithKline Plc - Segment focus
Exhibits139: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits140: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits141: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits142: ImmunogenX Inc. - Overview
Exhibits143: ImmunogenX Inc. - Product / Service
Exhibits144: ImmunogenX Inc. - Key offerings
Exhibits145: Johnson and Johnson Services Inc. - Overview
Exhibits146: Johnson and Johnson Services Inc. - Business segments
Exhibits147: Johnson and Johnson Services Inc. - Key news
Exhibits148: Johnson and Johnson Services Inc. - Key offerings
Exhibits149: Johnson and Johnson Services Inc. - Segment focus
Exhibits150: Precigen Inc. - Overview
Exhibits151: Precigen Inc. - Key offerings
Exhibits152: Sanofi SA - Overview
Exhibits153: Sanofi SA - Business segments
Exhibits154: Sanofi SA - Key news
Exhibits155: Sanofi SA - Key offerings
Exhibits156: Sanofi SA - Segment focus
Exhibits157: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits158: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits159: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits160: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits161: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits162: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits163: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits164: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits165: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Information sources
Exhibits171: Data validation
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Data synthesis
Exhibits174: 360 degree market analysis
Exhibits175: List of abbreviations